Literature DB >> 19806238

Histopathology of type 1 diabetes: old paradigms and new insights.

Ken T Coppieters1, Matthias G von Herrath.   

Abstract

Although our knowledge on the various aspects of diabetes development in the NOD mouse model is substantial and keeps expanding at a dramatic pace, the dataset on histopathologic features of type 1 diabetes (T1D) in patients remains largely stagnant. Early work has established an array of common aspects that have become epitomic in the absence of new patient material. There is a growing consensus that an updated and more detailed view is required that challenges and expands our understanding. Comprehensive initiatives are currently ongoing to address these issues in pre-diabetic, recent onset and longstanding type 1 diabetic individuals, and some of the old data have been recently revisited. In this review article, we wish to provide an overview of where we stand today and how we can correlate the various cross-sectional studies from the past with contemporary models of the disease. We believe an enhanced understanding of the many histopathological particularities in patients as compared to animal models will ultimately lead, not only to more fundamental insights, but also to an improved ability to translate pre-clinical data from bench to bedside.

Entities:  

Year:  2009        PMID: 19806238      PMCID: PMC2779010          DOI: 10.1900/RDS.2009.6.85

Source DB:  PubMed          Journal:  Rev Diabet Stud        ISSN: 1613-6071


  82 in total

Review 1.  The CVB and etiology of type 1 diabetes.

Authors:  K M Drescher; S M Tracy
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

2.  Insulin protein and proliferation in ductal cells in the transplanted pancreas of patients with type 1 diabetes and recurrence of autoimmunity.

Authors:  A Martin-Pagola; G Sisino; G Allende; J Dominguez-Bendala; R Gianani; H Reijonen; G T Nepom; C Ricordi; P Ruiz; J Sageshima; G Ciancio; G W Burke; A Pugliese
Journal:  Diabetologia       Date:  2008-08-12       Impact factor: 10.122

3.  Post-mortem analysis of islet pathology in type 1 diabetes illuminates the life and death of the beta cell.

Authors:  J Spencer; M Peakman
Journal:  Clin Exp Immunol       Date:  2009-02       Impact factor: 4.330

4.  Taking a closer look at the pancreas.

Authors:  K Coppieters; M von Herrath
Journal:  Diabetologia       Date:  2008-12       Impact factor: 10.122

5.  Analysis of pancreas tissue in a child positive for islet cell antibodies.

Authors:  M Oikarinen; S Tauriainen; T Honkanen; K Vuori; P Karhunen; C Vasama-Nolvi; S Oikarinen; C Verbeke; G E Blair; I Rantala; J Ilonen; O Simell; M Knip; H Hyöty
Journal:  Diabetologia       Date:  2008-08-12       Impact factor: 10.122

6.  Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans.

Authors:  Juris J Meier; Alexandra E Butler; Yoshifumi Saisho; Travis Monchamp; Ryan Galasso; Anil Bhushan; Robert A Rizza; Peter C Butler
Journal:  Diabetes       Date:  2008-03-11       Impact factor: 9.461

7.  Accumulation of autoreactive effector T cells and allo-specific regulatory T cells in the pancreas allograft of a type 1 diabetic recipient.

Authors:  J H Velthuis; W W Unger; A R van der Slik; G Duinkerken; M Engelse; A F Schaapherder; J Ringers; C van Kooten; E J de Koning; B O Roep
Journal:  Diabetologia       Date:  2008-12-23       Impact factor: 10.122

8.  High levels of endogenous tumor necrosis factor-related apoptosis-inducing ligand expression correlate with increased cell death in human pancreas.

Authors:  Ahter Dilsad Sanlioglu; Ercument Dirice; Ozlem Elpek; Aylin Fidan Korcum; Mustafa Kemal Balci; Abdulkadir Omer; Thomas S Griffith; Salih Sanlioglu
Journal:  Pancreas       Date:  2008-05       Impact factor: 3.327

Review 9.  Beta-cell mass and type 1 diabetes: going, going, gone?

Authors:  Eitan Akirav; Jake A Kushner; Kevan C Herold
Journal:  Diabetes       Date:  2008-11       Impact factor: 9.461

10.  Molecular composition of the peri-islet basement membrane in NOD mice: a barrier against destructive insulitis.

Authors:  H F Irving-Rodgers; A F Ziolkowski; C R Parish; Y Sado; Y Ninomiya; C J Simeonovic; R J Rodgers
Journal:  Diabetologia       Date:  2008-07-17       Impact factor: 10.122

View more
  24 in total

1.  Intravital imaging of CTLs killing islet cells in diabetic mice.

Authors:  Ken Coppieters; Natalie Amirian; Matthias von Herrath
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

Review 2.  Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host.

Authors:  Didier Hober; Pierre Sauter
Journal:  Nat Rev Endocrinol       Date:  2010-03-30       Impact factor: 43.330

Review 3.  Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes.

Authors:  Mark C Johnson; Bo Wang; Roland Tisch
Journal:  Hum Vaccin       Date:  2011-01-01

Review 4.  Viruses and cytotoxic T lymphocytes in type 1 diabetes.

Authors:  Ken T Coppieters; Matthias G von Herrath
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

Review 5.  Virus infections in type 1 diabetes.

Authors:  Ken T Coppieters; Tobias Boettler; Matthias von Herrath
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

6.  NF-κB and STAT1 control CXCL1 and CXCL2 gene transcription.

Authors:  Susan J Burke; Danhong Lu; Tim E Sparer; Thomas Masi; Matthew R Goff; Michael D Karlstad; J Jason Collier
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-11-26       Impact factor: 4.310

Review 7.  Clinical potential of antigen-specific therapies in type 1 diabetes.

Authors:  Ken T Coppieters; Birgit Sehested Hansen; Matthias G von Herrath
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 8.  Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes.

Authors:  Frank Waldron-Lynch; Kevan C Herold
Journal:  Nat Rev Drug Discov       Date:  2011-06       Impact factor: 84.694

9.  Large enteroviral vaccination studies to prevent type 1 diabetes should be well founded and rely on scientific evidence.

Authors:  Oskar Skog; Karin Klingel; Merja Roivainen; Olle Korsgren
Journal:  Diabetologia       Date:  2019-02-27       Impact factor: 10.122

Review 10.  Pathogenic mechanisms in type 1 diabetes: the islet is both target and driver of disease.

Authors:  Kate L Graham; Robyn M Sutherland; Stuart I Mannering; Yuxing Zhao; Jonathan Chee; Balasubramanian Krishnamurthy; Helen E Thomas; Andrew M Lew; Thomas W H Kay
Journal:  Rev Diabet Stud       Date:  2012-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.